<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03512899</url>
  </required_header>
  <id_info>
    <org_study_id>63850017.5.0000.5432</org_study_id>
    <nct_id>NCT03512899</nct_id>
  </id_info>
  <brief_title>Comparison Between Internal Jugular Vein Versus Axilar Vein for Implantable Ports</brief_title>
  <official_title>Internal Jugular Vein Versus Axilar Vein With Single-incision for Implantable Ports: a Prospective and Randomized Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AC Camargo Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AC Camargo Cancer Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Comparison between internal jugular vein versus via axilar vein with single-incision for
      placement of implantable ports in cancer patients. Investigators are recruiting 240 patients
      and randomizing 120 for each arm. Primary outcome is early complications, until 30 days and
      secondary outcome late complications, between 30 days and 6 months. The follow-up is 12
      months.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective and randomized trial comparing internal jugular vein versus via axilar vein with
      single-incision for placement of implantable ports in cancer patients. Investigators are
      recruiting 240 patients and randomizing 120 for each arm in a single center study at AC
      Camargo Cancer Center. Every surgery is assisted by ultrasound and radioscopic and the
      catheter is districath速, 8.5 French. Clinical assessment will be at 10 days and every 3
      months after surgery. Primary outcome is early complications, until 30 days and secondary
      outcome late complications, between 30 days and 6 months. The follow-up is 12 months.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2017</start_date>
  <completion_date type="Anticipated">July 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Comparison between internal jugular vein versus via axilar vein with single-incision for placement of implantable ports in cancer patients. Investigators are recruiting 240 patients and randomizing 120 for each arm. Primary outcome is early complications, until 30 days and secondary outcome late complications, between 30 days and 6 months. The follow-up is 6 months.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Early complications.</measure>
    <time_frame>30 days</time_frame>
    <description>Early complications within 30 days during clinical assessment. These outcomes are divided in intra-operative complications, such as pneumothorax, hemothorax, vascular injury, cardiac arrhythmia, hematoma; and post-operative until 30 days complications such as wound infections, catheter related bacteremia, catheter disfunction, catheter related deep venous thrombosis, reservoir extrusion and skin erosion.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Late complications</measure>
    <time_frame>30 to 180 days</time_frame>
    <description>Post-operative between 30 days and 6 months complications such as wound infections, catheter related bacteremia, catheter disfunction, catheter related deep venous thrombosis, reservoir extrusion and skin erosion.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Catheter Complications</condition>
  <condition>Cancer</condition>
  <arm_group>
    <arm_group_label>Internal jugular vein access</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Internal jugular vein access preferably right, assisted by ultrasound and radioscopy. Catheter: districath速, 8.5 French.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Axilar vein access</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Axilar vein access with single incision, assisted by ultrasound and radioscopy. Catheter: districath速, 8.5 French.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Right internal jugular access.</intervention_name>
    <description>Implantation using percutaneous puncture.</description>
    <arm_group_label>Internal jugular vein access</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Left internal jugular access.</intervention_name>
    <description>Implantation using percutaneous puncture.</description>
    <arm_group_label>Internal jugular vein access</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Right axilar vein access.</intervention_name>
    <description>Implantation using percutaneous puncture.</description>
    <arm_group_label>Axilar vein access</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Left axilar vein access.</intervention_name>
    <description>Implantation using percutaneous puncture.</description>
    <arm_group_label>Axilar vein access</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Catheter due to chemotherapy.

          -  Cancer patients.

          -  ECOG (performance status) from 0 to 2.

          -  Signed informed consent form.

        Exclusion Criteria:

          -  Non compliance.

          -  Anticoagulant therapy.

          -  Coagulopathy (platelet count below 50,000 and/or protrombin time above 18s).

          -  Death within 30 days after the procedure.

          -  Another catheter in superior vena cava.

          -  Previous long term catheter in superior vena cava.

          -  Obesity (IBM&gt;40 Kg/m2).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bruno S Pignataro</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vascular and Endovascular Surgery Department</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bruno S Pignataro, MD</last_name>
    <phone>551121895000</phone>
    <email>brunosoriano86@yahoo.com.br</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sandra C Serrano</last_name>
    <phone>551121895000</phone>
    <phone_ext>5020</phone_ext>
    <email>hcancer@accamargo.org.br</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>AC Camargo Cancer Center</name>
      <address>
        <city>S達o Paulo</city>
        <zip>01509-010</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kenji Nishinari, PHD</last_name>
      <phone>551121895000</phone>
    </contact>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 6, 2018</study_first_submitted>
  <study_first_submitted_qc>April 27, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 1, 2018</study_first_posted>
  <last_update_submitted>April 27, 2018</last_update_submitted>
  <last_update_submitted_qc>April 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 1, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>implantable port</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

